Efficacy of Pioglitazone in Participants With Inadequately Controlled Type 2 Diabetes Mellitus Treated With Stable Triple Oral Therapy

NCT01972724 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

114

Enrollment

INDUSTRY

Sponsor class

Conditions

Type II Diabetes Mellitus

Interventions

DRUG: Pioglitazone
DRUG: Metformin
DRUG: Sulfonylurea

Sponsor

Takeda